NRHA's Quality and Clinical Conference: Network and explore quality clinical care, as well as the Black Hills
July 20 - 22, 2011
Rapid City, SD
Make time to network with your colleagues at NRHA’s Quality and Clinical Conference July 20-22 in Rapid City, S.D. This interactive event is designed specifically for quality and performance improvement coordinators, researchers, hospital administrators, and doctors and nurses practicing on the front lines of rural health care.
Last year's attendees said the variety of topics presented was "excellent," and they loved the "real-world examples" of successful rural health care collaborations between hospitals and other organizations.
The sixth annual event will feature:
- telehealth and quality innovations and solutions
- a tour and hands-on demonstration of a mobile health unit that serves rural populations
- a keynote address from Mark Levine, MD, chief medical officer at the Denver Region Centers for Medicare and Medicaid Services
- the impact ACOs may have on rural hospitals, post-acute care and physician providers
» MORE INFORMATION
Webinar: A rapid, serial, multi-marker approach for managing acute coronary syndrome in the emergency department
June 9, 2011
11:00 AM - 12:00 PM EST
Upon completion of the program, the attendee will be able to:
- Review the history of ACS biomarkers
- Outline current guidelines for the diagnosis of chest pain patients
- Discuss the data supporting various strategies for the rapid triage of chest pain patients
This program is acceptable for up to 1 credit hour by P.A.C.E. Alere is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program.
» MORE INFORMATION
Webinar: The Joint Commission Hospital Standards for Emergency Management and the Survey Process
June 28, 2011 @ 1:00 PM ET
Is your hospital prepared for the next Joint Commission survey? These surveys are now unannounced, rather than planned, as they were in the past. When the surveyors come through your hospital’s door, key managers, directors, or members of the administrative staff may not be on site that day. The focus of accreditation is shifting from preparing for the "exam" to continuously using the standards as a means to achieve and maintain excellent operational systems, and deriving significant internal benefits.
Join our complimentary webcast presented by the Joint Commission to:
· Review key Joint Commission Emergency Management Standards
· Get suggestions to help your hospital meet these standards
· Identify best practices
· Learn what to expect during the survey process
Speaker:
David Dagenais, BS, SASHE, CHFM, CHSP
Life Safety Code Specialist
Mr. Dagenais has been a Joint Commission Life Safety Code Specialist since 2010 and is trained under the Accreditation Manual for Hospitals.
» REGISTER ONLINE
SNHPA Webinar: Rural/Free-Standing Cancer Hospital - Orphan Drug Discount Prohibition Proposed Regulation
June 8, 2011
1:00 - 2:15 PM ET
The Affordable Care Act (ACA) barred rural and free-standing cancer hospitals new to 340B from obtaining discounts on orphan drugs, which are often used to treat cancer and other serious diseases and conditions. They also include blood factor product used to treat bleeding disorders and expensive IVIG therapies. The orphan drug restriction does not impact DSH or children’s hospitals. SNHPA has been working diligently to address this problematic policy. The Health Resources and Services Administration (HRSA) on May 20 published a long-awaited proposed regulation on this matter. We are writing to invite you to participate in a webinar on Wednesday, June 8 from 1:00-2:15 PM (Eastern) to summarize the guidance and to get your input on the regulation and its impact on your hospital. SNHPA will submit comments to HRSA and will be asking our members to also comment. The proposed regulation would limit the prohibition on 340B pricing "to uses for the rare disease or condition for which the orphan drug was designated." Rural and cancer hospitals would be free to purchase an orphan drug at its 340B price if the drug is used for a non-orphan indication. The hospitals would have to put in place "tracking and recordkeeping requirements to demonstrate compliance with the limits on the use of orphan drugs.” We will address these requirements during the webinar and are eager to get your input.
The webinar is free for members and corporate partners and $50 for prospective member hospitals. Registration is required for all attendees. To register, click here for more information. The deadline is June 7th.
» GET MORE INFORMATION
SNHPA Webinar: Rural/Free-Standing Cancer Hospital - Orphan Drug Discount Prohibition Proposed Regulation
June 9, 2011
1:00 - 2:30 PM ET
The Affordable Care Act, which was enacted by Congress over a year ago, included a number of important provisions pertaining to the 340B drug discount program. Indeed, perhaps your hospital is now eligible for 340B thanks to this legislation. However, there are many new developments in 340B, developments which have significant implications for every hospital in this federal program. The government is expected to publish guidance imminently that is likely to restrict the patient populations and clinics eligible for 340B discounts. There are also efforts by Medicaid and other programs to reduce reimbursement to 340B providers. Finally, new regulations defining the scope of the orphan drug discount prohibition for newly eligible rural and free-standing cancer hospitals have just been issued by the government.
Safety Net Hospitals for Pharmaceutical Access (SNHPA), a non-profit membership organization that represents over 700 hospitals nationwide enrolled in 340B, is working hard to address these and other challenges. We encourage you to attend a complimentary webinar on Thursday, June 9 from 1:00-2:30 PM (Eastern Time) where you can learn about how your hospital can engage in SNHPA’s advocacy efforts, and how we can support you in reducing your hospital’s drug costs and ensuring compliance with this complex and dynamic federal program. You will also learn about SNHPA’s efforts aimed at extending 340B to the inpatient setting and lifting the orphan drug discount ban.
Who Should Attend: Pharmacy directors, CFO's, in-house counsel, government relations directors and compliance officers.
This event is free for hospitals, but registration is required.
» GET MORE INFORMATION » TOP |
